Pharmaceutical Composition of Ketorolac
The technology provides a prolonged release injectable preparation of ketorolac using ketorolac free acid or its salts. The liquid injectable dosage forms include stabilizers, complexing agents, antoxidants, preservatives, isotonicifiers, solubilizers, viscosity modifying agents, pH modifying agents and vehicles. The prolonged release of ketorolac is achieved by using a rate-retarding agent in vegetable oil (carrier medium). The sustained release of water soluble drugs is aimed at reducing the frequency of administration ofinjectable ketorolac formulations per day, for analgesic treatment. The technology further help in decreasing the side effects associated with parenteral therapy of ketorolac.
Sector: Pharmaceuticals
Country: India
Area of Application: Pharma industry.
Keywords: Ketorolac,Furthermore,intensive.
Advantages: “Prolonged release” of Ketorolac is the new concept Rapid recovery. Fit for both human and veterinary use Shorter hospital stay. Use for broad spectrum pain. Reduce hospitalization cost.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent
Technical specifications:  
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):  
Upload any relevant document:  
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054

Contact Technology Provider